 |
 |
|
| Startseite |
| Impressum |
| Datenschutz |
 |
| SPOT ON | |
Dabigatran (PRADAXA) for atrial fibrillation: Does benefit outweigh the risk? | |
| NEW ON THE MARKET | |
Telaprevir (INCIVO) against chronic hepatitis C | |
| THERAPY FROM A CRITICAL VIEWPOINT | |
Letrozole (FEMARA, generics) in the adjuvant treatment of breast cancer | |
| a-t READER'S QUESTIONS AND COMMENTS | |
Stinking rebate drugs | |
| IN BRIEF | |
Approval of bevacizumab (AVASTIN) for breast cancer revoked in the USA and Canada | |
| SIDE EFFECTS | |
Risk of thromboembolism with drospirenone (e.g. YASMIN) | |
| CURRENT ADR NETWORK REPORT | |
When the pneumococcal conjugate vaccine PREVENAR 13 flocculates | |
 |
|
|
© arznei-telegramm 12/2011 | ||
 |  | |